C4 Therapeutics (CCCC) Research & Development: 2019-2025
Historic Research & Development for C4 Therapeutics (CCCC) over the last 6 years, with Sep 2025 value amounting to $26.0 million.
- C4 Therapeutics' Research & Development fell 18.37% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.8 million, marking a year-over-year increase of 3.00%. This contributed to the annual value of $110.6 million for FY2024, which is 6.01% down from last year.
- As of Q3 2025, C4 Therapeutics' Research & Development stood at $26.0 million, which was down 0.79% from $26.2 million recorded in Q2 2025.
- C4 Therapeutics' Research & Development's 5-year high stood at $32.5 million during Q4 2024, with a 5-year trough of $20.5 million in Q1 2021.
- For the 3-year period, C4 Therapeutics' Research & Development averaged around $28.0 million, with its median value being $28.3 million (2023).
- In the last 5 years, C4 Therapeutics' Research & Development surged by 34.51% in 2022 and then declined by 22.41% in 2024.
- Over the past 5 years, C4 Therapeutics' Research & Development (Quarterly) stood at $26.6 million in 2021, then increased by 15.45% to $30.7 million in 2022, then declined by 0.85% to $30.4 million in 2023, then grew by 6.98% to $32.5 million in 2024, then declined by 18.37% to $26.0 million in 2025.
- Its last three reported values are $26.0 million in Q3 2025, $26.2 million for Q2 2025, and $27.1 million during Q1 2025.